The Company wishes to inform that a Meeting of the RIghts Issue Committee will be held on 9th April 2026 to approve some key parameters of the upcoming Rights Issue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd has scheduled a Rights Issue Committee meeting on April 9, 2026 to finalize parameters for a proposed partly paid-up Rights Issue. The committee will determine the total number of Rights Equity Shares to be issued, fix the Rights Issue Price, establish the Rights Entitlement Ratio, set the Rights Issue period, and identify the Record Date for eligible shareholders. They will also formally appoint a Monitoring Agency and Banker to manage fund flows and compliance. The specific purpose or intended use of the funds to be raised has not been disclosed in this filing.
This announcement signals the company is actively progressing with a capital raise via Rights Issue. For existing shareholders, a Rights Issue provides an opportunity to maintain their ownership percentage by purchasing additional shares, though it may lead to dilution if not participated in. The partly paid-up structure allows investors to pay in installments. The actual market impact will depend on the final pricing and ratio terms announced.